Clinical trial · Interventional
Supermicrosurgery for Breast Cancer Survivors With Lymphedema.
Supermicrosurgery for Breast Cancer Survivors With Lymphedema. -Prospective Randomized Clinical and Patient-reported Outcomes.
NCT03578380CI-TRIAL-00065758unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A randomised prospective investigation of volume and quality of life results with lymphovenous anastomosis in patients with unilateral arm lymphedema after breast cancer using Indocyanine Green lymphangiography and MD Anderson Staging.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Secondary Lymphedema | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Compression and drainage therapy | Other | — | UNRESOLVED |
| Surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Surgery
- description
- Lymphovenous anastomosis
- interventionNames
- Procedure: Surgery
- type
- ACTIVE_COMPARATOR
- label
- Compression
- description
- Conservative treatment with physiotherapy and compression
- interventionNames
- Other: Compression and drainage therapy
Primary outcomes (1)
- measure
- Volume
- timeFrame
- 12 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Unilateral lymphedema of the arm secondary to breast cancer treatment. Stage 1-3 operable lymphedema. Exclusion Criteria: * Frequent or severe cellulitis. All other lymphedema.
References
Publications (0)
Data not yet available
No reference posted for this study.